← Eichor
Condition: Early Stage Parkinson S Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Early Stage Parkinson S Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD)
NA · 1 location(s) · Taipei Medical University · NCT07619560A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's
Phase 2 · 70 location(s) · Neuron23 Inc. · NCT06680830Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
NA · 4 location(s) · Cilcare SAS · NCT07083089Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
NA · 1 location(s) · Radboud University Medical Center · NCT06193252A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Phase 1 · 18 location(s) · Mission Therapeutics · NCT07630545Effectiveness of Online Program and Task-related Training for Parkinson's Disease
NA · 1 location(s) · Chang Gung University · NCT06248073Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Ad
Phase N/A · 17 location(s) · AbbVie · NCT06916507A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreate
Phase 2 · 1 location(s) · GEN İlaç ve Sağlık Ürünleri A.Ş. · NCT07322887A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · 174 location(s) · Hoffmann-La Roche · NCT07174310Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Phase 1/Phase 2 · 1 location(s) · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · NCT07166757The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease
Phase 1 · 1 location(s) · iRegene Therapeutics Co., Ltd. · NCT06608355Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage P
Phase 2/Phase 3 · 1 location(s) · Zhejiang Vimgreen Pharmaceuticals, Ltd. · NCT07725562A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson'
Phase 2/Phase 3 · 15 location(s) · Biohaven Therapeutics Ltd. · NCT06976268
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.